Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Receivables (2024 - 2025)

Korro Bio (KRRO) has disclosed Receivables for 2 consecutive years, with $820000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Receivables fell 91.8% year-over-year to $820000.0, compared with a TTM value of $820000.0 through Sep 2025, down 91.8%, and an annual FY2024 reading of $1.7 million, changed N/A over the prior year.
  • Receivables was $820000.0 for Q3 2025 at Korro Bio, down from $1.1 million in the prior quarter.
  • Across five years, Receivables topped out at $10.0 million in Q3 2024 and bottomed at $820000.0 in Q3 2025.